|1.||Henkel, Birgit: 1 article (02/2006)|
|2.||Haagsman, Henk P: 1 article (02/2006)|
|3.||Terlou, Maarten: 1 article (02/2006)|
|4.||Sultan, Karim R: 1 article (02/2006)|
10/01/1989 - "As an in vitro model system for such changes in cell morphology, we have used cell cultures of the rat bladder carcinoma-derived cell line NBT-II which, on exposure to inducing medium containing a commercial serum substitute (Ultroser G), show an extensive change in their organization (epithelial-mesenchymal transition): the junctions between the epithelial cells are split, the epithelial cell organization is lost, and the resulting individual cells become motile and assume a spindle-like fibroblastoid appearance. "
01/01/1989 - "Scattering of NBT-II bladder carcinoma cell line was promoted by 2 distinct culture protocols: (i) deposition of some components of the extracellular matrix onto the culture substratum (glass or plastic) induced cell dispersion of the epithelial sheet of carcinoma cells, and (ii) addition of Ultroser G, a serum substitute, to the culture medium induced scattering and acquisition of motility of NBT-II cells. "
|2.||Intestinal Volvulus (Volvulus)
|3.||Wounds and Injuries (Trauma)
12/01/1989 - "Dialysis and fractionation of ultroser G indicated that high molecular weight factors (greater than 25,000 d) were required for epidermal wound closure."
12/01/1989 - "In the presence of fetal calf serum or ultroser G, a serum substitute, epidermal wound closure appeared in a concentration-dependent manner within 1 day of culture. "
10/01/1987 - "Whereas FGF, EGF, and UltroSer G showed similar stimulation of DNA synthesis and clonal growth in human adrenocortical cells and human adrenal gland fibroblasts, the tumor promoter 12-O-tetradecanoylphorbol-13-acetate stimulated growth only in adrenocortical cells and was strongly inhibitory to growth in fibroblasts. "
|1.||Proteins (Proteins, Gene)
|3.||Epidermal Growth Factor (EGF)
|4.||DNA (Deoxyribonucleic Acid)